Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
CA 2425583 A1 · Owner: Utku, Nalan · Inventors: Utku, Nalan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided are uses of agents interfering with the interaction of TIRC7 with its ligand such as HLA-(Human Leukocyte associated Antigen) class II alpha (.alpha.) chain for the preparation of pharmaceutical compositions for the treatment of graft versus host disease autoimmune diseases, allergic , diseases infectious diseases, sepsis, for the treatment of tumors for the , improvement of wound healing or for inducing or maintaining immune unresponsiveness in a subject. In addition methods for identifying and , obtaining such agents are described. Furthermore methods of diagnosing an , immune disease or a tumor by determining the presence or absence of TIRC7 ligand are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.